Clinical Trials Platform

Participate in groundbreaking clinical research that advances the MAHA movement's mission to address chronic disease through innovative, evidence-based interventions and treatments.

Advancing Preventive Medicine Research

NexGenHealth.io's Clinical Trials Platform connects patients, researchers, and healthcare providers to accelerate the development of innovative treatments that address the root causes of chronic disease. Our focus aligns with MAHA principles, emphasizing prevention, nutrition interventions, and non-invasive therapeutic approaches.

Current Trial Focus Areas

Nutritional Interventions

  • Whole food vs. ultra-processed diet studies
  • Micronutrient deficiency correction trials
  • Intermittent fasting protocols
  • Anti-inflammatory diet interventions
  • Personalized nutrition based on genetics

Digital Health Technologies

  • Wearable device intervention studies
  • AI-powered health coaching trials
  • Telemedicine effectiveness research
  • Digital therapeutic applications
  • Remote patient monitoring systems

Environmental Health Studies

  • Toxin exposure reduction interventions
  • Air quality improvement impact studies
  • Chemical-free lifestyle transitions
  • Environmental factor disease correlation
  • Detoxification protocol efficacy

Chronic Disease Prevention

  • Type 2 diabetes prevention trials
  • Cardiovascular disease intervention
  • Metabolic syndrome reversal studies
  • Autoimmune condition management
  • Neurodegenerative disease prevention

Featured Active Trials

MAHA Nutrition Reset Study (2025-2027)

Objective: Assess the impact of eliminating ultra-processed foods on biomarkers of chronic disease in 5,000 participants over 24 months.

Status: Actively recruiting • Phase: III • Duration: 2 years

Primary Endpoints: HbA1c reduction, inflammatory marker improvement, weight normalization, medication reduction

Digital Health Coach AI Trial (2024-2026)

Objective: Evaluate AI-powered health coaching effectiveness for chronic disease management compared to standard care in 2,500 patients.

Status: Enrolling • Phase: II/III • Duration: 18 months

Primary Endpoints: Clinical outcome improvement, patient engagement, healthcare cost reduction

Environmental Detox Intervention Study (2025-2026)

Objective: Investigate structured environmental toxin reduction protocols on childhood developmental disorder symptoms in 1,000 families.

Status: Starting recruitment • Phase: II • Duration: 12 months

Primary Endpoints: Symptom severity reduction, biomarker normalization, quality of life improvement

Participant Benefits

  • Access to Cutting-Edge Treatments: Early access to innovative therapies before they become widely available
  • Comprehensive Health Monitoring: Extensive health assessments and monitoring at no cost
  • Personalized Care: Individualized treatment plans and close medical supervision
  • Contributing to Medical Advancement: Help develop treatments that will benefit millions of people
  • Expert Medical Team: Access to leading researchers and clinicians
  • Financial Support: Potential compensation for time and travel expenses

Eligibility & Participation

Trial eligibility varies by study, but we welcome participants from diverse backgrounds and health conditions. Our platform uses AI-powered matching to connect you with trials that best fit your health profile and goals. All participants receive comprehensive informed consent and can withdraw at any time.

15+

Active Clinical Trials

8,500+

Enrolled Participants

98%

Participant Satisfaction